A detailed history of Sanctuary Advisors, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Sanctuary Advisors, LLC holds 23,951 shares of RPRX stock, worth $937,921. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,951
Previous 15,612 53.41%
Holding current value
$937,921
Previous $562 Million 32.55%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Jan 06, 2026

BUY
$34.9 - $37.91 $291,031 - $316,131
8,339 Added 53.41%
23,951 $746 Million
Q2 2025

Jan 06, 2026

SELL
$30.85 - $36.14 $257,258 - $301,371
-8,339 Reduced 34.82%
15,612 $562 Million
Q1 2025

Jan 06, 2026

SELL
$25.75 - $33.86 $461,002 - $606,195
-17,903 Reduced 42.77%
23,951 $746 Million
Q4 2024

Jan 31, 2025

BUY
$24.28 - $28.39 $9,420 - $11,015
388 Added 0.94%
41,854 $1.32 Billion
Q3 2024

Nov 25, 2024

BUY
$25.63 - $29.27 $1.06 Million - $1.21 Million
41,466 New
41,466 $1.1 Billion

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $17.1B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Sanctuary Advisors, LLC Portfolio

Follow Sanctuary Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanctuary Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sanctuary Advisors, LLC with notifications on news.